Rising demand for rapid diagnostics drives cardiac marker market toward $9.6b

Point-of-care testing is expected to be the fastest-growing segment.

The global cardiac marker testing market is projected to grow from about $5.54b in 2026 to $9.06b by 2031, according to MarketsandMarkets™.

Growth is driven by rising adoption of point-of-care testing, increasing demand for rapid results in emergency care, and the growing burden of cardiovascular diseases linked to aging populations and lifestyle conditions such as obesity and diabetes.

The shift toward decentralised healthcare systems is also supporting market expansion.

Technological advancements are further accelerating growth, including high-sensitivity biomarker assays, laboratory automation, multiplex testing, and integration of digital health systems. These innovations are improving diagnostic speed, accuracy, and clinical decision-making.

By product, reagents and kits held the largest share in 2026, supported by strong demand for accurate and fast diagnostic tools and rising cardiovascular disease incidence.

Continued expansion of diagnostic laboratories is also driving usage.

Point-of-care testing is expected to be the fastest-growing segment over the forecast period due to the need for immediate results in emergency settings and increased adoption in critical care environments.